CADL
Candel Therapeutics·NASDAQ
--
--(--)
--
--(--)
8.08 / 10
Outperform
Analyst sentiment is overwhelmingly bullish: 100% Strong Buy from two analysts with 66.7%–100% historical win rates. Fund‑flow score 7.69 is good, showing overall inflow, though Small and Medium blocks are negative. Combined, the outlook leans strongly positive.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
John NewmanStrong Buy
Date2026-03-13
InstitutionCanaccord Genuity
Times predicted1
Historical Win Rate100.0%
Yigal NochomovitzStrong Buy
What is the analyst consensus for CADL?
- CADL holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.08/10 (Outperform).
